vs

Side-by-side financial comparison of Coursera, Inc. (COUR) and Sotera Health Co (SHC). Click either name above to swap in a different company.

Sotera Health Co is the larger business by last-quarter revenue ($303.4M vs $196.9M, roughly 1.5× Coursera, Inc.). Sotera Health Co runs the higher net margin — 11.5% vs -13.6%, a 25.1% gap on every dollar of revenue. On growth, Coursera, Inc. posted the faster year-over-year revenue change (9.9% vs 4.6%). Sotera Health Co produced more free cash flow last quarter ($52.4M vs $5.4M). Over the past eight quarters, Sotera Health Co's revenue compounded faster (10.6% CAGR vs 7.9%).

Coursera Inc. is an American for-profit online university, earlier operating as a global massive open online course provider from 2012 until 2021. It was founded in 2012 by Stanford University computer science professors Andrew Ng and Daphne Koller. Coursera works with universities and other organizations to offer online courses, certifications, and degrees in a variety of subjects.

Sotera Health Co is a global provider of end-to-end medical safety solutions. It offers sterilization services, analytical laboratory testing, and regulatory advisory support for medical device manufacturers, pharmaceutical firms, and food and consumer product companies, helping clients meet industry standards and ensure product safety for end users worldwide.

COUR vs SHC — Head-to-Head

Bigger by revenue
SHC
SHC
1.5× larger
SHC
$303.4M
$196.9M
COUR
Growing faster (revenue YoY)
COUR
COUR
+5.3% gap
COUR
9.9%
4.6%
SHC
Higher net margin
SHC
SHC
25.1% more per $
SHC
11.5%
-13.6%
COUR
More free cash flow
SHC
SHC
$47.0M more FCF
SHC
$52.4M
$5.4M
COUR
Faster 2-yr revenue CAGR
SHC
SHC
Annualised
SHC
10.6%
7.9%
COUR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COUR
COUR
SHC
SHC
Revenue
$196.9M
$303.4M
Net Profit
$-26.8M
$34.8M
Gross Margin
54.2%
54.7%
Operating Margin
-16.4%
23.2%
Net Margin
-13.6%
11.5%
Revenue YoY
9.9%
4.6%
Net Profit YoY
-24.1%
182.8%
EPS (diluted)
$-0.16
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COUR
COUR
SHC
SHC
Q4 25
$196.9M
$303.4M
Q3 25
$194.2M
$311.3M
Q2 25
$187.1M
$294.3M
Q1 25
$179.3M
$254.5M
Q4 24
$179.2M
$290.2M
Q3 24
$176.1M
$285.5M
Q2 24
$170.3M
$276.6M
Q1 24
$169.1M
$248.2M
Net Profit
COUR
COUR
SHC
SHC
Q4 25
$-26.8M
$34.8M
Q3 25
$-8.6M
$48.4M
Q2 25
$-7.8M
$8.0M
Q1 25
$-7.8M
$-13.3M
Q4 24
$-21.6M
$12.3M
Q3 24
$-13.7M
$17.0M
Q2 24
$-22.9M
$8.8M
Q1 24
$-21.3M
$6.3M
Gross Margin
COUR
COUR
SHC
SHC
Q4 25
54.2%
54.7%
Q3 25
54.6%
57.0%
Q2 25
54.9%
56.6%
Q1 25
54.6%
53.2%
Q4 24
53.3%
56.6%
Q3 24
54.6%
55.4%
Q2 24
53.0%
55.2%
Q1 24
52.9%
51.2%
Operating Margin
COUR
COUR
SHC
SHC
Q4 25
-16.4%
23.2%
Q3 25
-8.0%
23.4%
Q2 25
-8.1%
6.4%
Q1 25
-8.0%
-5.8%
Q4 24
-17.0%
30.0%
Q3 24
-12.3%
28.2%
Q2 24
-18.3%
27.8%
Q1 24
-17.6%
21.4%
Net Margin
COUR
COUR
SHC
SHC
Q4 25
-13.6%
11.5%
Q3 25
-4.4%
15.5%
Q2 25
-4.2%
2.7%
Q1 25
-4.4%
-5.2%
Q4 24
-12.1%
4.2%
Q3 24
-7.8%
6.0%
Q2 24
-13.4%
3.2%
Q1 24
-12.6%
2.5%
EPS (diluted)
COUR
COUR
SHC
SHC
Q4 25
$-0.16
$0.12
Q3 25
$-0.05
$0.17
Q2 25
$-0.05
$0.03
Q1 25
$-0.05
$-0.05
Q4 24
$-0.13
$0.05
Q3 24
$-0.09
$0.06
Q2 24
$-0.15
$0.03
Q1 24
$-0.14
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COUR
COUR
SHC
SHC
Cash + ST InvestmentsLiquidity on hand
$792.6M
$344.6M
Total DebtLower is stronger
$2.1B
Stockholders' EquityBook value
$635.7M
$606.0M
Total Assets
$1.0B
$3.3B
Debt / EquityLower = less leverage
3.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COUR
COUR
SHC
SHC
Q4 25
$792.6M
$344.6M
Q3 25
$797.7M
$299.2M
Q2 25
$775.1M
$332.4M
Q1 25
$748.0M
$304.4M
Q4 24
$726.1M
$277.2M
Q3 24
$719.4M
$306.7M
Q2 24
$708.8M
$246.1M
Q1 24
$725.4M
$261.1M
Total Debt
COUR
COUR
SHC
SHC
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$2.2B
Q2 24
$2.2B
Q1 24
$2.2B
Stockholders' Equity
COUR
COUR
SHC
SHC
Q4 25
$635.7M
$606.0M
Q3 25
$639.5M
$550.5M
Q2 25
$627.0M
$511.3M
Q1 25
$610.5M
$414.1M
Q4 24
$597.4M
$404.9M
Q3 24
$593.3M
$470.2M
Q2 24
$585.2M
$422.8M
Q1 24
$609.1M
$429.4M
Total Assets
COUR
COUR
SHC
SHC
Q4 25
$1.0B
$3.3B
Q3 25
$995.3M
$3.2B
Q2 25
$979.9M
$3.2B
Q1 25
$951.2M
$3.1B
Q4 24
$930.3M
$3.1B
Q3 24
$914.1M
$3.1B
Q2 24
$904.4M
$3.1B
Q1 24
$916.3M
$3.1B
Debt / Equity
COUR
COUR
SHC
SHC
Q4 25
3.53×
Q3 25
3.89×
Q2 25
4.34×
Q1 25
5.36×
Q4 24
5.49×
Q3 24
4.73×
Q2 24
5.26×
Q1 24
5.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COUR
COUR
SHC
SHC
Operating Cash FlowLast quarter
$5.8M
$103.1M
Free Cash FlowOCF − Capex
$5.4M
$52.4M
FCF MarginFCF / Revenue
2.7%
17.3%
Capex IntensityCapex / Revenue
0.2%
16.7%
Cash ConversionOCF / Net Profit
2.96×
TTM Free Cash FlowTrailing 4 quarters
$107.2M
$149.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COUR
COUR
SHC
SHC
Q4 25
$5.8M
$103.1M
Q3 25
$33.9M
$71.2M
Q2 25
$35.5M
$57.4M
Q1 25
$33.5M
$55.5M
Q4 24
$19.2M
$55.7M
Q3 24
$27.9M
$97.5M
Q2 24
$23.8M
$61.3M
Q1 24
$24.5M
$9.7M
Free Cash Flow
COUR
COUR
SHC
SHC
Q4 25
$5.4M
$52.4M
Q3 25
$33.7M
$35.0M
Q2 25
$35.1M
$26.2M
Q1 25
$33.0M
$35.6M
Q4 24
$18.1M
$-10.2M
Q3 24
$27.7M
$61.1M
Q2 24
$23.6M
$19.4M
Q1 24
$24.4M
$-25.2M
FCF Margin
COUR
COUR
SHC
SHC
Q4 25
2.7%
17.3%
Q3 25
17.4%
11.2%
Q2 25
18.8%
8.9%
Q1 25
18.4%
14.0%
Q4 24
10.1%
-3.5%
Q3 24
15.7%
21.4%
Q2 24
13.9%
7.0%
Q1 24
14.4%
-10.2%
Capex Intensity
COUR
COUR
SHC
SHC
Q4 25
0.2%
16.7%
Q3 25
0.1%
11.6%
Q2 25
0.2%
10.6%
Q1 25
0.3%
7.8%
Q4 24
0.6%
22.7%
Q3 24
0.1%
12.7%
Q2 24
0.1%
15.2%
Q1 24
0.1%
14.1%
Cash Conversion
COUR
COUR
SHC
SHC
Q4 25
2.96×
Q3 25
1.47×
Q2 25
7.21×
Q1 25
Q4 24
4.52×
Q3 24
5.73×
Q2 24
7.00×
Q1 24
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COUR
COUR

Consumer Segment$131.5M67%
Enterprise Segment$65.4M33%

SHC
SHC

Transferred At Point In Time$198.4M65%
Nelson Labs$55.2M18%
Nordion$49.8M16%

Related Comparisons